Medical Marijuana Laws and Adolescent Marijuana Use in the USA from 1991 to 2014

Results from Annual, Repeated Cross-Sectional Surveys
Published in: The Lancet Psychiatry, v. 2, no. 7, July 2015, p. 601-608


Adolescent use of marijuana is associated with adverse later effects, so the identification of factors underlying adolescent use is of substantial public health importance. The relationship between US state laws that permit marijuana for medical purposes and adolescent marijuana use has been controversial. Such laws could convey a message about marijuana acceptability that increases its use soon after passage, even if implementation is delayed or the law narrowly restricts its use. We used 24 years of national data from the USA to examine the relationship between state medical marijuana laws and adolescent use of marijuana.


Using a multistage, random-sampling design with replacement, the Monitoring the Future study conducts annual national surveys of 8th, 10th, and 12th-grade students (modal ages 13–14, 15–16, and 17–18 years, respectively), in around 400 schools per year. Students complete self-administered questionnaires that include questions on marijuana use. We analysed data from 1,098,270 adolescents surveyed between 1991 and 2014. The primary outcome of this analysis was any marijuana use in the previous 30 days. We used multilevel regression modelling with adolescents nested within states to examine two questions. The first was whether marijuana use was higher overall in states that ever passed a medical marijuana law up to 2014. The second was whether the risk of marijuana use changed after passage of medical marijuana laws. Control covariates included individual, school, and state-level characteristics.


Marijuana use was more prevalent in states that passed a medical marijuana law any time up to 2014 than in other states (adjusted prevalence 15·87% vs 13·27%; adjusted odds ratio [OR] 1·27, 95% CI 1·07–1·51; p=0·0057). However, the risk of marijuana use in states before passing medical marijuana laws did not differ significantly from the risk after medical marijuana laws were passed (adjusted prevalence 16·25% vs 15·45%; adjusted OR 0·92, 95% CI 0·82–1·04; p=0·185). Results were generally robust across sensitivity analyses, including redefining marijuana use as any use in the previous year or frequency of use, and reanalysing medical marijuana laws for delayed effects or for variation in provisions for dispensaries.


Our findings, consistent with previous evidence, suggest that passage of state medical marijuana laws does not increase adolescent use of marijuana. However, overall, adolescent use is higher in states that ever passed such a law than in other states. State-level risk factors other than medical marijuana laws could contribute to both marijuana use and the passage of medical marijuana laws, and such factors warrant investigation.

Related Topics :


Medical marijuana does not increase adolescent marijuana use

In The Lancet Psychiatry, Deborah Hasin and colleagues1 review the relationship between US state medical marijuana laws and adolescent use of marijuana. Marijuana is the most commonly used illicit drug, both worldwide and in the USA, where around 19·8 million Americans use it per month.2, 3 Although millions use it for recreational or medicinal purposes, the risks of regular use, including cognitive difficulties, worsening anxiety and mood, as well as addiction, are well documented, especially for adolescents whose brains are still developing.4 These risks underscore the essential need for sound, evidence-based marijuana policies, when states in the USA are considering laws regulating marijuana decriminalisation, medical marijuana, and legalisation of the recreational use of marijuana. With so much at stake, intense, often emotional, discussions have been taking place both in the USA and globally on these complex issues.

The effect of medical marijuana laws remains a controversial topic in the USA. As of May 2015, 23 US states and the District of Columbia have medical marijuana laws in place that permit the use of marijuana medicinally, under the supervision of physicians, for a wide range of medical indications. Although the scientific rationale for medical marijuana might be debated, many people would agree that the implementation of medical marijuana laws has been complex. Concerns about medical marijuana in the states that have enacted such laws include that access to medical marijuana dispensaries could be difficult, that physicians face challenges in recommending its use to patients, and that the regulations themselves could be either too broad or too restrictive5 with regard to the recommended quantities of marijuana and the medical indications specified by medical marijuana laws.

Perhaps the main concern of many people opposed to medical marijuana laws is that they will lead to increased general marijuana use, including among adolescents. According to the Monitoring the Future survey,6 marijuana use is following a trajectory unlike nicotine, alcohol, or opioids: marijuana use among adolescents has actually increased in recent years, while the perception of the risk of marijuana in this group has steadily fallen.6 If the proportion of adolescent marijuana users who develop addiction remains constant at approximately 17%,7 then any increases in adolescent use could mean an increased number of adolescents becoming addicted to marijuana as well.7 Despite these concerns and trends, previous studies examining medical marijuana laws and adolescent marijuana use have not been conclusive. Schuermeyer and colleagues8 suggested adolescent marijuana use in Colorado increased after medical marijuana laws were passed there compared with states without such laws, whereas two multistate studies9, 10 did not show increased adolescent marijuana use after passage of medical marijuana laws.8

In their study, Hasin and colleagues1 used results from the Monitoring the Future study that includes data from more than one million US adolescents aged 13–18 years in roughly 400 schools in the 48 contiguous states of the USA during a 24-year span. Controlling for individual-level, school-level, and state-level factors, in states with medical marijuana laws the investigators noted no differences in adolescent marijuana use before or after the passage of these laws (adjusted prevalence 16·25% vs 15·45%; adjusted odds ratio [OR] 0·92, 95% CI 0·82–1·04; p=0·185). Adolescent marijuana use was more prevalent in states that enacted medical marijuana laws than in states without these laws (adjusted prevalence 15·87% vs 13·27%; adjusted OR 1·27, 1·07–1·51; p=0·0057), but the fact that medical marijuana laws did not change the prevalence of use suggests that several factors have a role in affecting adolescent marijuana use. Hasin and colleagues postulated, as many would, that the passage of medical marijuana laws would increase adolescent marijuana use by contributing to the declining perception of the potential harms of marijuana. Their well designed, methodologically sound study showed that this was not the case.

This study draws attention to the importance of undertaking rigorous scientific research to test hypotheses and using the results to develop sensible health policies. Policies might sometimes be shaped by preconceived notions that do not end up being true, and Hasin and colleagues’ study1 is an example of such an occurrence—an easy assumption to make would be that medical marijuana laws would increase access to marijuana, and therefore use among adolescents would increase, especially in view of the aforementioned trends in use and perceptions of risk. However, the growing body of research that includes this study suggests that medical marijuana laws do not increase adolescent use, and future decisions that states make about whether or not to enact medical marijuana laws should be at least partly guided by this evidence. The framework of using the scientific method to challenge what might be ideological beliefs must remain an important driver of future research on marijuana policy.

References :

  1. Hasin, DS, Wall, M, Keyes, KM et al. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry. 2015; (published online June 16. )
  2. Degenhardt, L, Whiteford, HA, Ferrari, AJ et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382: 1564–1574
  3. Substance Abuse and Mental Health Services Administration. Results from the 2013 national survey on drug use and health: summary of national findings. Substance Abuse and Mental Health Services Administration, Rockville; 2014
  4. Volkow, ND, Baler, RD, Compton, WM, and Weiss, SRB. Adverse health effects of marijuana use. N Engl J Med. 2014; 370: 2219–2227
  5. Hill, KP. Medical marijuana: more questions than answers. J Psychiatr Pract. 2014; 20: 389–391
  6. Johnston, LD, O’Malley, PM, Miech, RA et al. Monitoring the Future: national survey results on drug use. Institute for Social Research, University of Michigan, Ann Arbor; 2014 ((accessed June 1, 2015).)
  7. Hall, W and Degenhardt, L. Adverse health effects of non-medical cannabis use. Lancet. 2009; 374: 1383–1391
  8. Schuermeyer, J, Salomonsen-Sautel, S, Price, RK et al. Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003–11. Drug Alcohol Depend. 2014; 140: 145–155
  9. Lynne-Lansdman, SD, Livingston, MD, and Wagenaar, AC. Effects of state medical marijuana laws on adolescent marijuana use. Am J Public Health. 2013; 103: 1500–1506
  10. Choo, EK, Benz, M, Zaller, N, Warren, O, Rising, KL, and McConnell, KJ. The impact of state medical marijuana legislation on adolescent marijuana use. J Adolesc Health. 2014; 55: 160–166
Posté dans Autres Auteurs, English, Politiques des drogues / Actualités.